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Figure 1: Image showing the presence of blisters and some exulcerations 
on forearms and buttocks. Histopathological examination reveals 
subepidermal blisters containing rare neutrophils and eosinophils. 
Case 1 
A 31-year-old male presented with confluent erythematous blisters and 
some hard crusts on his forearms, buttocks and thighs. Histopathological 
examination of one of the lesions was performed, showing subepidermal 
blisters containing rare neutrophils and eosinophils. A moderate mononuclear 
and neutrophilic infiltrate consistent with dermatitis herpetiformis was 
observed around the vessels in the superficial dermis (figure 1).
Treatment consisted of a gluten-free diet.
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Case 2
A 6-year-old female initially presented with 
vesicles in the nasal region and on her forearms 
and lower limbs; some of the lesions evolved to 
crusts. Pruritus was presented. The condition was 
first treated as bullous impetigo, and had improved 
with treatment. However, only a few days after 
finishing treatment, the patient developed new 
vesicles in previously healed areas of the forearms. 
Histopathological examination of the lesion 
was performed, showing a subepidermal blister 
containing neutrophils, corresponding to dermatitis 
herpetiformis (figure 2).
Figure 2:  Image showing the presence of blister in a previous healed area. Histopathological 
examination reveals a subepidermal blister containing neutrophils.
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Treatment consisted of a gluten-free diet 
and dapsone 25mg/day, and the patient showed 
improvement of the lesions.
Dermatitis herpetiformis or Duhring-Brocq 
disease is an autoimmune disease with the 
presence of a pruritic papular rash with symmetrical 
blisters on knees, elbows, scalp1-3. The mucous 
membrane is usually preserved4. 
It is characterized as a rare disease, with 
a prevalence varying according to the country 
examined. In adult male patients, this disease had 
a ratio of 2:1; however, under 20-year-old female 
patients are the most affected, with a ratio of 12:83. 
Additionally, cases of dermatitis herpetiformis have 
been reported in the same family3, and 10-12% of 
patients had spontaneous remission2.
Its histopathology is characterized by 
subepidermal blisters with neutrophilic infiltrate 
at the apex of the papillary dermis1,3,4. Direct 
immunofluorescence shows granular IgA 
deposits1-3. 
Celiac disease antibodies can also be found 
in dermatitis herpetiformis2. Because it is an 
autoimmune disease, the presence of thyroid 
disease, diabetes mellitus type 1, pernicious 
anemia, and connective tissue disease should be 
investigated3. 
The treatment of Duhring- Brocq’s disease must 
be performed to make the lesions disappear and 
to reduce the risk of gastrointestinal lymphoma4. 
The patient should do a gluten-free diet or receive 
dapsone or derivatives of sulfones1. 
Dapsone shows rapid improvement of the skin 
condition, but it does not act in the gastrointestinal 
tract, which is an important aspect to be considered, 
since patients can show structural alterations of the 
gastrointestinal mucosa even without symptoms 
of celiac disease1. Patients using dapsone are 
required to follow gluten-free diet for at least five 
months before beginning to wean off medication, 
and weaning has to be slow and gradual because 
of the high chance of recurrence1. 
Since a gluten-free diet improves both the skin 
condition and the gastrointestinal tract, as proven 
by histopathology, it is the only treatment that 
reduces the risk of gastrointestinal lymphoma1,3,4. 
Sulfapyridine and sulfasalazine are less 
effective than dapsone, but these medications lead 
to a greater improvement in the skin condition and 
in the gastrointestinal environment1.
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